What is Alto Ingredients, Inc.'s earnings per share (EPS)?

Alto Ingredients, Inc. (ALTO) reported diluted earnings per share of $0.16 for fiscal year 2025. This represents a 119.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Alto Ingredients, Inc. (ALTO) Financials

ALTO

Trailing 12 months to June 30, 2026

Revenue $943.3M +1.1% YoY

Net Income $38.7M +589.1% YoY

EPS (Diluted) $0.68 +173.9% YoY

Free Cash Flow $49.9M +481.7% YoY

Market Cap $289.3M as of Oct 9, 2026

Price / Sales 0.3x on $943.3M revenue, trailing 12 months to June 30, 2026

Price / Earnings 7.5x on $38.7M net income, trailing 12 months to June 30, 2026

Price / Book 1.1x on $259.9M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 7, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALTO SEC filings page.

Alto Ingredients, Inc. (ALTO) reported $943.3M in revenue over the twelve months to Jun 30, 2026, up 1.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALTO FY2025 2026-10-03

The business restored positive cash generation through margin recovery and lighter reinvestment, while interest expense still exceeded operating profit.

Operating cash flow turned positive at $13.2M even as revenue fell 4.9% from FY2024, so the improvement came from the cost and investment profile rather than sales volume. Gross margin rose to 3.8% while capital spending fell to $4.6M, linking cash improvement to better spread plus lighter reinvestment.

At $917.9M of revenue, FY2025 lifted operating margin to 0.8% despite a smaller sales base. That pattern is more consistent with cost or mix improvement than volume-driven fixed-cost absorption, so the recovery is not simply a scale story.

The balance sheet became less leveraged: debt-to-equity fell to 0.3x while the current ratio held at 2.6x, indicating lower leverage with retained short-term coverage. Yet interest expense of $10.8M exceeded $7.4M of operating income, leaving reported net income near breakeven despite positive operating profit.

Financial Health Signals

Financial Health Score 33/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Alto Ingredients, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Alto Ingredients, Inc. has an operating margin of 0.8%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 27/100, suggesting thin profitability after operating expenses. This is up from -5.3% the prior year.

Growth

Alto Ingredients, Inc.'s revenue declined 4.9% year-over-year, from $965.3M to $917.9M. This contraction results in a growth score of 7/100.

Leverage

Alto Ingredients, Inc. has a moderate D/E ratio of 0.26. This balance of debt and equity financing earns a leverage score of 43/100.

Liquidity

With a current ratio of 2.64, Alto Ingredients, Inc. holds $2.64 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 73/100.

Cash Flow

Alto Ingredients, Inc.'s free cash flow margin of 0.9% results in a low score of 25/100. Capital expenditures of $4.6M absorb a large share of operating cash flow.

Returns

Alto Ingredients, Inc. generates a 0.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 21/100. This is unchanged from the prior year.

Altman Z-Score Distress

1.01

Alto Ingredients, Inc. scores 1.01, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($289.3M) relative to total liabilities ($143.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Alto Ingredients, Inc. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

N/A

Alto Ingredients, Inc. reported $13K of net income while generating $13.2M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Interest Coverage At Risk

0.68x

Alto Ingredients, Inc. earns $0.68 in operating income for every $1 of interest expense ($7.4M vs $10.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$245.7M

YoY+12.5%

QoQ+9.4%

5Y CAGR-3.8%

10Y CAGR-5.3%

Alto Ingredients, Inc. generated $245.7M in revenue in Q2 2026. This represents an increase of 12.5% from the same quarter a year earlier. Against the prior quarter it is up 9.4%.

EBITDA

$15.1M

YoY+964.7%

QoQ+69.6%

5Y CAGR+4.8%

Alto Ingredients, Inc.'s EBITDA was $15.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 964.7% from the same quarter a year earlier. Against the prior quarter it is up 69.6%.

Net Income

$11.7M

YoY+206.4%

QoQ+174.0%

5Y CAGR+6.9%

10Y CAGR+8.7%

Alto Ingredients, Inc. reported $11.7M in net income in Q2 2026. This represents an increase of 206.4% from the same quarter a year earlier. Against the prior quarter it is up 174.0%.

EPS (Diluted)

$0.15

YoY+200.0%

QoQ+200.0%

5Y CAGR+6.4%

Alto Ingredients, Inc. earned $0.15 per diluted share (EPS) in Q2 2026. This represents an increase of 200.0% from the same quarter a year earlier. Against the prior quarter it is up 200.0%.

Cash & Balance Sheet

Free Cash Flow

$17.9M

YoY+1443.9%

QoQ+442.5%

5Y CAGR+16.7%

10Y CAGR+16.9%

Alto Ingredients, Inc. generated $17.9M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 1443.9% from the same quarter a year earlier. Against the prior quarter it is up 442.5%.

Cash & Debt

$24.0M

YoY-19.5%

QoQ+18.0%

5Y CAGR-14.0%

10Y CAGR-2.8%

Alto Ingredients, Inc. held $24.0M in cash against $60.5M in long-term debt as of Q2 2026.

Shares Outstanding

78M

YoY+0.2%

QoQ+0.1%

5Y CAGR+1.3%

10Y CAGR+6.9%

Alto Ingredients, Inc. had 78M shares outstanding in Q2 2026. This represents an increase of 0.2% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

6.8%

YoY+7.7pp

QoQ+2.7pp

5Y change+1.7pp

10Y change+2.4pp

Alto Ingredients, Inc.'s gross margin was 6.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 7.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.

Operating Margin

3.5%

YoY+7.2pp

QoQ+2.4pp

5Y change+1.5pp

10Y change+0.8pp

Alto Ingredients, Inc.'s operating margin was 3.5% in Q2 2026, reflecting core business profitability. This is up 7.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.

Net Margin

4.8%

YoY+9.8pp

QoQ+2.9pp

5Y change+2.0pp

10Y change+3.6pp

Alto Ingredients, Inc.'s net profit margin was 4.8% in Q2 2026, showing the share of revenue converted to profit. This is up 9.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.9 percentage points.

Return on Equity

4.5%

YoY+9.8pp

QoQ+2.8pp

5Y change+1.8pp

10Y change+3.1pp

Alto Ingredients, Inc.'s ROE was 4.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 9.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.8 percentage points.

Capital Allocation

Capital Expenditures

$10.6M

YoY+2085.5%

QoQ+1063.7%

5Y CAGR+117.2%

10Y CAGR+15.4%

Alto Ingredients, Inc. invested $10.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 2085.5% from the same quarter a year earlier. Against the prior quarter it is up 1063.7%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

ALTO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALTO quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$943.3M	$917.9M-4.9%	$965.3M-21.1%	$1.2B-8.4%	$1.3B+10.6%	$1.2B+34.7%	$897.0M-37.0%	$1.4B-6.0%	$1.5B-7.2%	$1.6B+0.5%	$1.6B+35.8%	$1.2B+8.0%	$1.1B+21.5%	$911.8M+11.7%	$816.0M-9.4%	$901.2M
Cost of Revenue	$878.8M	$883.0M-7.6%	$955.5M-20.9%	$1.2B-11.4%	$1.4B+19.6%	$1.1B+35.1%	$844.2M-41.2%	$1.4B-6.3%	$1.5B-5.9%	$1.6B+3.6%	$1.6B+33.0%	$1.2B+18.2%	$998.9M+14.1%	$875.5M+4.8%	$835.6M-5.2%	$881.8M
Gross Profit	$64.5M	$34.9M+259.1%	$9.7M-37.9%	$15.7M+156.8%	-$27.6M-140.6%	$67.8M+28.2%	$52.9M+631.9%	-$9.9M+34.5%	-$15.2M-355.7%	$5.9M-89.1%	$54.4M+424.4%	$10.4M-90.4%	$108.5M+229.4%	$32.9M+268.7%	-$19.5M-200.6%	$19.4M
SG&A Expenses	$28.6M	$27.2M-8.5%	$29.7M-0.4%	$29.9M+6.4%	$28.1M-3.8%	$29.2M-8.7%	$32.0M-9.8%	$35.5M-2.5%	$36.4M+15.4%	$31.5M+2.2%	$30.8M+17.0%	$26.4M+54.1%	$17.1M+22.0%	$14.0M+15.5%	$12.1M-21.3%	$15.4M
Operating Income	$35.6M	$7.4M+114.2%	-$51.7M-116.7%	-$23.8M+61.1%	-$61.4M-253.1%	$40.1M+306.7%	$9.9M+113.2%	-$74.7M-44.9%	-$51.5M-101.4%	-$25.6M-208.8%	$23.5M+230.8%	-$18.0M-119.7%	$91.4M+383.2%	$18.9M+159.7%	-$31.7M-897.2%	$4.0M
EBITDA	N/A	$32.6M+219.5%	-$27.3M-3450.4%	-$768K+97.9%	-$36.3M-157.2%	$63.4M+57.9%	$40.1M+249.9%	-$26.8M-150.5%	-$10.7M-181.8%	$13.1M-77.8%	$59.0M+941.5%	$5.7M-94.6%	$104.6M+236.8%	$31.0M+259.5%	-$19.5M-217.1%	$16.6M
Interest Expense	$9.4M	$10.8M+40.8%	$7.6M+2.9%	$7.4M+306.4%	$1.8M-49.1%	$3.6M-80.0%	$17.9M-11.2%	$20.2M+17.9%	$17.1M+32.4%	$12.9M-42.3%	$22.4M+77.9%	$12.6M+33.4%	$9.4M-39.8%	$15.7M+20.1%	$13.0M-11.9%	$14.8M
Income Tax	N/A	-$621K-459.0%	$173K+78.4%	$97K-95.0%	$1.9M+31.0%	$1.5M+8741.2%	-$17K+15.0%	-$20K+96.4%	-$562K-75.1%	-$321K+67.3%	-$981K+90.2%	-$10.0M-166.3%	$15.1M	$0	$0	N/A
Net Income	$38.7M	$13K+122.6%	-$59K+99.8%	-$29.3M+31.7%	-$42.9M-196.9%	$44.2M+392.5%	-$15.1M+83.0%	-$88.9M-47.6%	-$60.3M-72.4%	-$35.0M-2564.0%	$1.4M+107.6%	-$18.8M-188.2%	$21.3M+2825.9%	-$781K+95.9%	-$19.1M-719.9%	$3.1M
EPS (Basic)	N/A	$0.16+119.5%	-$0.82-105.0%	-$0.40+33.3%	-$0.60-196.8%	$0.62+321.4%	-$0.28+85.3%	-$1.90-33.8%	-$1.42-67.1%	-$0.85	$0.00+100.0%	-$0.60-164.5%	$0.93+647.1%	-$0.17+94.0%	-$2.81-5720.0%	$0.05
EPS (Diluted)	$0.68	$0.16+119.5%	-$0.82	-$0.40+33.3%	-$0.60-198.4%	$0.61+317.9%	-$0.28+85.3%	-$1.90-33.8%	-$1.42-67.1%	-$0.85	$0.00+100.0%	-$0.60-169.8%	$0.86	-$0.17	-$2.81	$0.05
Diluted Shares (Avg)	N/A	76M+3.0%	73M	73M+1.9%	72M-0.4%	72M+123121.7%	58,609-99.9%	47M+109140.1%	43,376+1.5%	42,745+1.2%	42,251+27.4%	33,173-99.9%	23M	12M	7M	33,984

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$245.7M+12.5%	$224.7M-0.8%	$232.0M-1.9%	$241.0M-4.3%	$218.4M-7.6%	$226.5M-5.9%	$236.3M-13.6%	$251.8M-20.8%
Cost of Revenue	$229.1M+3.9%	$215.5M-5.6%	$216.8M-8.8%	$217.5M-11.5%	$220.4M-3.7%	$228.3M-6.0%	$237.7M-13.9%	$245.9M-21.7%
Gross Profit	$16.6M+958.9%	$9.2M+610.2%	$15.2M+1190.1%	$23.5M+294.2%	-$1.9M-125.6%	-$1.8M+24.7%	-$1.4M+44.9%	$6.0M+43.2%
SG&A Expenses	$8.0M+29.9%	$6.7M-6.8%	$7.3M+37.5%	$6.5M-13.3%	$6.2M-31.1%	$7.2M-9.4%	$5.3M-4.5%	$7.5M-11.5%
Operating Income	$8.6M+206.3%	$2.5M+128.0%	$7.5M+119.1%	$17.0M+2458.3%	-$8.1M-475.9%	-$9.0M+12.9%	-$39.2M-128.4%	-$720K+83.4%
EBITDA	$15.1M+964.7%	$8.9M+425.4%	$13.8M+142.3%	$23.2M+335.3%	-$1.7M-137.3%	-$2.7M+40.7%	-$32.7M-184.7%	$5.3M+304.4%
Interest Expense	$2.0M-30.3%	$2.2M-19.5%	$2.4M-24.7%	$2.8M+50.0%	$2.8M+68.4%	$2.7M+208.0%	$3.2M-68.8%	$1.9M+193.3%
Net Income	$11.7M+206.4%	$4.3M+136.6%	$8.5M-50.7%	$14.2M+682.1%	-$11.0M-254.1%	-$11.7M+0.4%	$17.2M+185.2%	-$2.4M+30.0%
EPS (Basic)	$0.15+200.0%	$0.05+131.3%	$0.29+150.9%	$0.19+575.0%	-$0.15-200.0%	-$0.16+5.9%	-$0.57-119.2%	-$0.04+20.0%
EPS (Diluted)	$0.15+200.0%	$0.05+131.3%	$0.29+150.9%	$0.19+575.0%	-$0.15-200.0%	-$0.16+5.9%	-$0.57-119.2%	-$0.04+20.0%
Diluted Shares (Avg)	77M+3.3%	77M+3.8%	N/A	75M+1.3%	75M+1.5%	74M+1.5%	N/A	74M+0.9%

Not reported in any period shown, so not listed: R&D Expenses, Income Tax.

ALTO Balance Sheet

ALTO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$388.8M-3.2%	$401.4M-11.6%	$454.2M-5.0%	$478.3M-1.4%	$485.0M+1.7%	$476.8M-22.2%	$612.5M-7.2%	$660.0M-8.4%	$720.3M+1.7%	$708.2M+5.0%	$674.7M+126.5%	$297.9M+23.6%	$241.0M+12.1%	$215.0M-7.5%	$232.5M
Current Assets	$155.9M+1.8%	$153.1M-9.3%	$168.8M-15.2%	$199.1M-13.2%	$229.5M+7.2%	$214.0M-7.8%	$232.1M+37.5%	$168.8M-16.9%	$203.2M-13.6%	$235.2M+18.8%	$197.9M+43.5%	$137.9M+73.8%	$79.4M+38.2%	$57.4M-13.5%	$66.4M
Cash & Equivalents	$23.4M-34.0%	$35.5M+18.2%	$30.0M-17.7%	$36.5M-28.0%	$50.6M+6.2%	$47.7M+150.9%	$19.0M-28.7%	$26.6M-46.2%	$49.5M-23.0%	$64.3M+24.7%	$51.5M-17.0%	$62.1M+1105.1%	$5.2M-32.1%	$7.6M-14.9%	$8.9M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$61.7M+23.6%	$49.9M-5.1%	$52.6M-21.0%	$66.6M+22.5%	$54.4M+43.4%	$37.9M-37.4%	$60.6M+4.8%	$57.8M-6.1%	$61.5M+2.5%	$60.1M-1.2%	$60.8M+227.9%	$18.6M-20.7%	$23.4M+44.0%	$16.2M+0.7%	$16.1M
Accounts Receivable	$55.1M-5.4%	$58.2M-0.9%	$58.7M-14.5%	$68.7M-21.0%	$86.9M+99.8%	$43.5M-41.5%	$74.3M+9.9%	$67.6M-15.8%	$80.3M-6.9%	$86.3M+40.6%	$61.3M+77.2%	$34.6M-1.9%	$35.3M+35.5%	$26.1M-7.4%	$28.1M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	$6.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$143.5M-18.6%	$176.4M+1.0%	$174.7M+2.6%	$170.2M+21.8%	$139.7M-22.6%	$180.6M-53.2%	$385.4M+13.2%	$340.6M+1.2%	$336.6M+16.1%	$290.0M-4.3%	$303.1M+279.3%	$79.9M-45.3%	$146.1M+2.9%	$142.1M-23.4%	$185.5M
Current Liabilities	$59.1M+2.2%	$57.8M-11.5%	$65.3M-16.3%	$78.0M+12.1%	$69.6M-19.9%	$86.9M-45.8%	$160.4M-30.8%	$231.9M+155.6%	$90.7M+15.0%	$78.8M+8.1%	$72.9M+186.5%	$25.4M-9.8%	$28.2M+127.3%	$12.4M-23.8%	$16.3M
Non-Current Liabilities	$84.5M-28.8%	$118.6M+8.4%	$109.4M+18.6%	$92.2M+31.5%	$70.1M-25.1%	$93.7M-58.4%	$225.1M+106.9%	$108.8M-55.8%	$245.9M+16.5%	$211.1M-8.3%	$230.2M+322.7%	$54.5M-53.8%	$117.9M-9.0%	$129.6M-23.4%	$169.2M
Long-Term Debt	$63.0M-32.2%	$92.9M+13.2%	$82.1M+20.1%	$68.4M+35.7%	$50.4M-29.9%	$71.8M-60.3%	$180.8M+113.3%	$84.8M-61.7%	$221.1M+17.6%	$188.0M-7.8%	$203.9M+490.3%	$34.5M-64.9%	$98.4M-16.1%	$117.3M+25.2%	$93.7M
Total Equity	$245.2M+9.0%	$225.1M-19.5%	$279.6M-9.3%	$308.1M-10.8%	$345.2M+16.5%	$296.2M+30.5%	$227.0M-28.9%	$319.4M-10.4%	$356.4M-8.1%	$387.9M+4.4%	$371.5M+74.0%	$213.5M+139.3%	$89.2M+69.7%	$52.6M+11.9%	$47.0M
Retained Earnings	-$812.1M+1.5%	-$824.2M-7.9%	-$763.9M-4.0%	-$734.6M-6.2%	-$691.8M+6.1%	-$736.6M-2.3%	-$720.2M-14.3%	-$630.0M-10.8%	-$568.5M-6.8%	-$532.2M0.0%	-$532.4M-3.9%	-$512.3M+3.8%	-$532.4M-0.4%	-$530.3M-4.0%	-$510.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$397.1M+1.0%	$386.3M-4.0%	$388.8M-3.2%	$388.5M-6.9%	$393.1M-9.1%	$402.2M-7.5%	$401.4M-11.6%	$417.4M-9.5%
Current Assets	$160.8M+7.4%	$158.6M+3.3%	$155.9M+1.8%	$150.9M+4.0%	$149.7M-2.6%	$153.5M+1.7%	$153.1M-9.3%	$145.2M-13.7%
Cash & Equivalents	$24.0M-19.5%	$20.3M-24.2%	$23.4M-34.0%	$32.5M-3.2%	$29.8M+9.7%	$26.8M-8.6%	$35.5M+18.2%	$33.6M+28.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$51.6M-4.2%	$52.8M+4.4%	$61.7M+23.6%	$53.4M+11.2%	$53.9M+9.0%	$50.6M+18.8%	$49.9M-5.1%	$48.0M-15.9%
Accounts Receivable	$67.9M+18.2%	$59.7M-8.8%	$55.1M-5.4%	$54.8M+5.2%	$57.5M-10.3%	$65.5M+12.7%	$58.2M-0.9%	$52.0M-21.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$137.2M-25.9%	$136.4M-27.6%	$143.5M-18.6%	$166.1M+8.2%	$185.2M+11.1%	$188.3M+13.4%	$176.4M+1.0%	$153.5M-5.9%
Current Liabilities	$50.4M+18.5%	$41.7M-21.6%	$59.1M+2.2%	$42.4M-5.9%	$42.5M-14.6%	$53.1M-3.5%	$57.8M-11.5%	$45.1M-22.8%
Non-Current Liabilities	$86.8M-39.2%	$94.8M-29.9%	$84.5M-28.8%	$123.7M+14.1%	$142.7M+22.1%	$135.2M+21.9%	$118.6M+8.4%	$108.4M+3.5%
Long-Term Debt	$60.5M-48.9%	$73.1M-34.0%	$63.0M-32.2%	$100.6M+20.7%	$118.3M+30.1%	$110.7M+31.6%	$92.9M+13.2%	$83.3M+9.8%
Total Equity	$259.9M+25.0%	$249.9M+16.8%	$245.2M+9.0%	$222.4M-15.7%	$207.8M-21.8%	$213.9M-20.4%	$225.1M-19.5%	$263.9M-11.4%
Retained Earnings	-$796.7M+6.0%	-$808.1M+3.4%	-$812.1M+1.5%	-$833.6M-6.6%	-$847.5M-8.7%	-$836.2M-7.8%	-$824.2M-7.9%	-$782.1M-5.0%

Not reported in any period shown, so not listed: Goodwill.

ALTO Cash Flow Statement

ALTO quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$65.0M	$13.2M+476.2%	-$3.5M-116.0%	$22.0M+264.1%	$6.0M-77.4%	$26.8M-62.6%	$71.7M+329.5%	-$31.2M-2094.1%	$1.6M-95.7%	$36.5M-1.9%	$37.2M+233.0%	-$28.0M-131.7%	$88.3M+522.6%	$14.2M+168.1%	-$20.8M-427.7%	-$4.0M
Depreciation & Amortization	N/A	$25.2M+3.3%	$24.4M+5.8%	$23.1M-8.0%	$25.1M+7.7%	$23.3M-23.0%	$30.3M-36.8%	$47.9M+17.3%	$40.8M+5.7%	$38.7M+9.1%	$35.4M+50.0%	$23.6M+79.2%	$13.2M+8.7%	$12.1M-0.6%	$12.2M-3.5%	$12.6M
Stock-Based Compensation	N/A	$3.0M-30.6%	$4.4M+11.8%	$3.9M+16.9%	$3.3M+15.6%	$2.9M+7.6%	$2.7M-4.6%	$2.8M-18.3%	$3.4M-10.2%	$3.8M+46.3%	$2.6M+29.6%	$2.0M+9.8%	$1.8M+6.6%	$1.7M+113.9%	$806K-64.6%	$2.3M
Capital Expenditures	$15.1M	$4.6M-58.5%	$11.1M-62.5%	$29.5M-21.8%	$37.7M+130.4%	$16.4M+149.0%	$6.6M+100.5%	$3.3M-78.3%	$15.2M-27.4%	$20.9M+8.8%	$19.2M-6.5%	$20.5M+54.7%	$13.3M+232.1%	$4.0M+75.7%	$2.3M-3.9%	$2.4M
Free Cash Flow	$49.9M	$8.6M+159.3%	-$14.6M-94.3%	-$7.5M+76.3%	-$31.7M-403.7%	$10.4M-84.0%	$65.1M+288.7%	-$34.5M-154.0%	-$13.6M-186.9%	$15.6M-13.4%	$18.1M+137.2%	-$48.5M-164.6%	$75.1M+636.4%	$10.2M+144.1%	-$23.1M-266.1%	-$6.3M
Investing Cash Flow	-$8.4M	-$7.4M+44.8%	-$13.5M+59.2%	-$33.0M+12.3%	-$37.7M-238.9%	$27.1M+16.3%	$23.3M+810.6%	-$3.3M+78.3%	-$15.2M+70.0%	-$50.4M-245.6%	-$14.6M-130.8%	-$6.3M	N/A	N/A	-$12.3M-6.9%	-$11.5M
Financing Cash Flow	-$63.2M	-$16.4M-311.9%	$7.7M+10.9%	$7.0M-63.4%	$19.0M+147.5%	-$40.0M+39.8%	-$66.4M-449.3%	$19.0M+305.0%	-$9.3M-1005.4%	-$839K+91.5%	-$9.9M-141.7%	$23.8M	N/A	N/A	$31.8M+103.7%	$15.6M
Share Buybacks	N/A	N/A	N/A	$3.7M+177.3%	$1.3M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$28.5M+3458.4%	$4.2M+123.1%	$9.5M+197.4%	$22.8M+22.7%	-$848K+93.8%	-$18.2M-1375.8%	-$9.8M-183.0%	$18.6M-19.7%
Depreciation & Amortization	$6.5M+1.4%	$6.4M+1.6%	$6.3M-3.4%	$6.3M+3.3%	$6.4M+4.8%	$6.3M+9.4%	$6.5M+14.9%	$6.1M+7.3%
Stock-Based Compensation	N/A	$705K-16.9%	N/A	N/A	N/A	$848K-25.7%	N/A	N/A
Capital Expenditures	$10.6M+2085.5%	$909K+70.9%	$1.9M+52.4%	$1.6M+232.6%	$484K-89.6%	$532K-88.5%	$1.3M-74.0%	$491K-92.6%
Free Cash Flow	$17.9M+1443.9%	$3.3M+117.6%	$7.6M+168.6%	$21.2M+17.0%	-$1.3M+92.8%	-$18.8M-483.8%	-$11.1M-261.0%	$18.1M+9.6%
Investing Cash Flow	-$10.6M-288.3%	-$909K+88.4%	$4.7M+470.9%	-$1.6M-1694.5%	-$2.7M+55.0%	-$7.8M-29.2%	-$1.3M+74.0%	-$91K+98.6%
Financing Cash Flow	-$15.6M-326.1%	-$7.3M-143.1%	-$21.7M-347.5%	-$18.5M-120.4%	$6.9M+12.6%	$17.0M+1309.7%	$8.8M+134.7%	-$8.4M-24.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ALTO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALTO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	3.8%+2.8pp	1.0%-0.3pp	1.3%+3.3pp	-2.1%-7.7pp	5.6%-0.3pp	5.9%+6.6pp	-0.7%+0.3pp	-1.0%-1.4pp	0.4%-3.0pp	3.4%+2.5pp	0.9%-8.9pp	9.8%+6.2pp	3.6%+6.0pp	-2.4%-4.5pp	2.1%
Operating Margin	0.8%+6.2pp	-5.3%-3.4pp	-1.9%+2.6pp	-4.6%-7.9pp	3.3%+2.2pp	1.1%+6.3pp	-5.2%-1.8pp	-3.4%-1.8pp	-1.6%-3.0pp	1.5%+2.9pp	-1.5%-9.8pp	8.3%+6.2pp	2.1%+5.9pp	-3.9%-4.3pp	0.4%
Net Margin	0.0%0.0pp	0.0%+2.4pp	-2.4%+0.8pp	-3.2%-6.9pp	3.7%+5.3pp	-1.7%+4.5pp	-6.2%-2.3pp	-4.0%-1.8pp	-2.1%-2.2pp	0.1%+1.7pp	-1.6%-3.5pp	1.9%+2.0pp	-0.1%+2.3pp	-2.3%-2.7pp	0.3%
Return on Equity	0.0%0.0pp	0.0%+10.4pp	-10.5%+3.4pp	-13.9%-26.7pp	12.8%+17.9pp	-5.1%+34.1pp	-39.2%-20.3pp	-18.9%-9.1pp	-9.8%-10.2pp	0.4%+5.4pp	-5.1%-15.0pp	10.0%+10.8pp	-0.9%+35.4pp	-36.3%-42.8pp	6.5%
Return on Assets	0.0%0.0pp	0.0%+6.4pp	-6.4%+2.5pp	-9.0%-18.1pp	9.1%+12.3pp	-3.2%+11.3pp	-14.5%-5.4pp	-9.1%-4.3pp	-4.9%-5.1pp	0.2%+3.0pp	-2.8%-9.9pp	7.1%+7.5pp	-0.3%+8.6pp	-8.9%-10.2pp	1.3%
Current Ratio	2.640.0x	2.65+0.1x	2.580.0x	2.55-0.7x	3.30+0.8x	2.46+1.0x	1.45+0.7x	0.73-1.5x	2.24-0.7x	2.98+0.3x	2.71-2.7x	5.42+2.6x	2.81-1.8x	4.63+0.6x	4.08
Debt-to-Equity	0.26-0.2x	0.41+0.1x	0.29+0.1x	0.22+0.1x	0.15-0.1x	0.24-0.6x	0.80+0.5x	0.27-0.4x	0.62+0.1x	0.48-0.1x	0.55+0.4x	0.16-0.9x	1.10-1.1x	2.23+0.2x	1.99
Asset Turnover	2.360.0x	2.40-0.3x	2.69-0.1x	2.79+0.3x	2.49+0.6x	1.88-0.4x	2.330.0x	2.300.0x	2.270.0x	2.29+0.5x	1.77-1.9x	3.72-0.1x	3.780.0x	3.80-0.1x	3.88
FCF Margin	0.9%+2.5pp	-1.5%-0.9pp	-0.6%+1.8pp	-2.4%-3.2pp	0.9%-6.4pp	7.3%+9.7pp	-2.4%-1.5pp	-0.9%-1.9pp	1.0%-0.2pp	1.1%+5.2pp	-4.0%-10.8pp	6.8%+5.7pp	1.1%+4.0pp	-2.8%-2.1pp	-0.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	6.8%+7.7pp	4.1%+4.9pp	6.5%+7.1pp	9.8%+7.4pp	-0.9%-4.1pp	-0.8%+0.2pp	-0.6%+0.3pp	2.4%+1.1pp
Operating Margin	3.5%+7.2pp	1.1%+5.1pp	3.2%+19.8pp	7.0%+7.3pp	-3.7%-3.1pp	-4.0%+0.3pp	-16.6%-10.3pp	-0.3%+1.1pp
Net Margin	4.8%+9.8pp	1.9%+7.1pp	3.7%-3.6pp	5.9%+6.9pp	-5.0%-3.7pp	-5.2%-0.3pp	7.3%+14.7pp	-1.0%+0.1pp
Return on Equity	4.5%+9.8pp	1.7%+7.2pp	3.5%-4.2pp	6.4%+7.3pp	-5.3%-4.1pp	-5.5%-1.1pp	7.6%+14.9pp	-0.9%+0.3pp
Return on Assets	2.9%+5.8pp	1.1%+4.0pp	2.2%-2.1pp	3.7%+4.2pp	-2.8%-2.1pp	-2.9%-0.2pp	4.3%+8.7pp	-0.6%+0.2pp
Current Ratio	3.19-0.3x	3.81+0.9x	2.640.0x	3.56+0.3x	3.52+0.4x	2.89+0.1x	2.65+0.1x	3.22+0.3x
Debt-to-Equity	0.23-0.3x	0.29-0.2x	0.26-0.2x	0.45+0.1x	0.57+0.2x	0.52+0.2x	0.41+0.1x	0.32+0.1x
Asset Turnover	0.62+0.1x	0.580.0x	0.600.0x	0.620.0x	0.560.0x	0.560.0x	0.590.0x	0.60-0.1x
FCF Margin	7.3%+7.9pp	1.5%+9.8pp	3.3%+8.0pp	8.8%+1.6pp	-0.6%+7.2pp	-8.3%-6.9pp	-4.7%-7.2pp	7.2%+2.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Alto Ingredients, Inc. ALTO	FY2025	$917.9M	$13K	0.0%	$289.3M	33/100
Trinseo PLC TSE	FY2025	$3.0B	-$545.6M	-18.3%	$8.3M	16/100
5E Advanced Materials, Inc. FEAM	FY2026	N/A	-$42.9M	N/A	$151.6M	—
Loop Industries, Inc. LOOP	FY2026	$514K	-$12.3M	N/A	$20.3M	—
Aemetis, Inc. (DE) AMTX	FY2025	$197.6M	-$77.0M	-39.0%	$119.8M	33/100
Northern Technologies International Corp. NTIC	FY2025	$84.2M	$18K	0.0%	$73.0M	51/100

Where Alto Ingredients, Inc. Ranks

Frequently Asked Questions

What is Alto Ingredients, Inc.'s annual revenue?

Alto Ingredients, Inc. (ALTO) reported $917.9M in total revenue for fiscal year 2025. This represents a -4.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Alto Ingredients, Inc.'s revenue growing?

Alto Ingredients, Inc. (ALTO) revenue declined by 4.9% year-over-year, from $965.3M to $917.9M in fiscal year 2025.

Is Alto Ingredients, Inc. profitable?

Yes, Alto Ingredients, Inc. (ALTO) reported a net income of $13K in fiscal year 2025, with a net profit margin of 0.0%.

What is Alto Ingredients, Inc.'s EBITDA?

Alto Ingredients, Inc. (ALTO) had EBITDA of $32.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Alto Ingredients, Inc. have?

As of fiscal year 2025, Alto Ingredients, Inc. (ALTO) had $23.4M in cash and equivalents against $63.0M in long-term debt.

What is Alto Ingredients, Inc.'s gross margin?

Alto Ingredients, Inc. (ALTO) had a gross margin of 3.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Alto Ingredients, Inc.'s operating margin?

Alto Ingredients, Inc. (ALTO) had an operating margin of 0.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Alto Ingredients, Inc.'s net profit margin?

Alto Ingredients, Inc. (ALTO) had a net profit margin of 0.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Alto Ingredients, Inc.'s return on equity (ROE)?

Alto Ingredients, Inc. (ALTO) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Alto Ingredients, Inc.'s free cash flow?

Alto Ingredients, Inc. (ALTO) generated $8.6M in free cash flow during fiscal year 2025. This represents a 159.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Alto Ingredients, Inc.'s operating cash flow?

Alto Ingredients, Inc. (ALTO) generated $13.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Alto Ingredients, Inc.'s total assets?

Alto Ingredients, Inc. (ALTO) had $388.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Alto Ingredients, Inc.'s capital expenditures?

Alto Ingredients, Inc. (ALTO) invested $4.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Alto Ingredients, Inc. have outstanding?

Alto Ingredients, Inc. (ALTO) had 77M shares outstanding as of fiscal year 2025.

What is Alto Ingredients, Inc.'s current ratio?

Alto Ingredients, Inc. (ALTO) had a current ratio of 2.64 as of fiscal year 2025, which is generally considered healthy.

What is Alto Ingredients, Inc.'s debt-to-equity ratio?

Alto Ingredients, Inc. (ALTO) had a debt-to-equity ratio of 0.26 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Alto Ingredients, Inc.'s return on assets (ROA)?

Alto Ingredients, Inc. (ALTO) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Alto Ingredients, Inc.'s P/E ratio?

Alto Ingredients, Inc. (ALTO) trades at 7.5x earnings, its market capitalization divided by net income of $38.7M net income, trailing 12 months to June 30, 2026. The market capitalization is $289.3M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Alto Ingredients, Inc.'s price-to-sales ratio?

Alto Ingredients, Inc. (ALTO) trades at 0.3x sales, its market capitalization divided by revenue of $943.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $289.3M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Alto Ingredients, Inc.'s Altman Z-Score?

Alto Ingredients, Inc. (ALTO) has an Altman Z-Score of 1.01, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Alto Ingredients, Inc.'s Piotroski F-Score?

Alto Ingredients, Inc. (ALTO) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Alto Ingredients, Inc.'s earnings high quality?

Alto Ingredients, Inc. (ALTO) reported $13K of net income while generating $13.2M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Alto Ingredients, Inc. cover its interest payments?

Alto Ingredients, Inc. (ALTO) has an interest coverage ratio of 0.68x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Alto Ingredients, Inc.?

Alto Ingredients, Inc. (ALTO) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.